world stock markets


Best Biotech ETF: The biotech sector has been greatly outperforming the broader markets over the past three months. In fact, the Nasdaq Biotechnology sector has climbed more than 14% since June, while the Dow is up just 2% in that time.

And we see those biotech gains continuing from here. That’s why we’re bringing readers the best biotech ETF to buy now.

Right now, the biotech sector is in the early stages of a significant rally. And the best biotech ETF that we’re recommending today is poised for market-beating gains through the end of 2016 and into 2017.


You see, the biotech sector fell 31% from July 2015 through February 2016. But since then, the sector has staged a sharp recovery.

Don’t Miss: This is your ticket to bigger and better returns… and it won’t cost you a penny. What are you waiting for? Read more…

world stock markets: China Evergrande Group (EGRNF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    For example, Evergrande Life – a unit of property developer China Evergrande Group (OTC:EGRNF) – saw its premiums increase more than 40-fold in 2016. It used the proceeds to accumulate a significant stake in rival developer China Vanke (OTC:CVKEY) last year.

world stock markets: Hudson Technologies, Inc.(HDSN)


Advisors’ Opinion:

  • [By Lisa Levin]

    Hudson Technologies, Inc. (NASDAQ: HDSN) shares dropped 13 percent to $6.55 amid concerning guidance. The company said it is expecting Q3 EPS of $0.03-$0.05 versus an analyst consensus estimate of $0.10. Sales are expected to be around $25 million versus the analyst estimate of nearly $41 million.

  • [By WWW.THESTREET.COM]

    Finally, Cramer said Hudson Technologies (HDSN) was a great stock to own in 2016, when shares soared 170%, but this year, he cannot recommend this high-flying refrigeration company.

world stock markets: Christopher & Banks Corporation(CBK)


Advisors’ Opinion:

  • [By Lisa Levin]

    Christopher & Banks Corporation (NYSE: CBK) shares were also up, gaining 40 percent to $2.64. Christopher & Banks reported a Q4 loss of $0.24 per share on revenue of $94.6 million. The company projects Q1 revenue of $93 million to $98 million.

  • [By Lisa Levin]

    Shares of Christopher & Banks Corporation (NYSE: CBK) got a boost, shooting up 24 percent to $1.50 after the company reported strong preliminary revenue for the third quarter.

world stock markets: Skyworks Solutions, Inc.(SWKS)


Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    We also favor Skyworks Solutions (SWKS), a previous winner in our model portfolio which is expected to end its recent earnings slump in 2017 following the Apple (AAPL), long a staple among our stock picks, has just spurted ahead again. Once as high as $132, it slumped to $90 in 2015 on growth skepticism.

  • [By Lisa Levin] Gainers Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate. Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA. Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17. Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents. Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash. TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone. Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale. BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA. Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday. Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million. Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday. Sorl Auto
  • [By WWW.THESTREET.COM]

    But Skyworks  (SWKS) reported a remarkable quarter, yet it’s getting hit.

    It showed some terrific Internet of Things orders and not just Apple  (AAPL) and Samsung, although both are excellent customers in a very big year.

  • [By Andrew Tonner]

    One of the best ways to invest in broad-based movements such as the IoT is by buying shares in the companies that supply the hardware and infrastructure powering the trend — such asSkyworks Solutions (NASDAQ:SWKS) and NXP Semiconductor (NASDAQ:NXPI). Let’s dig into each company to see what makes them two of the top IoT investments on the market today.

world stock markets: Emerald Health Therapeutics, Inc. (TBQBF)


Advisors’ Opinion:

  • [By Javier Hasse]

    Emerald Health Therapeutics Inc (OTC: TBQBF) raised C$13.8 million ($10.5 million) under a bought deal financing.

    “The money will be primarily used for facility expansion."

    The Green Solution received a $7.5 million loan facility from iAnthus Capital Holdings Inc (OTC: ITHUF).

world stock markets: Noah Holdings Ltd.(NOAH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Noah Holdings Limited (ADR) (NYSE: NOAH) is estimated to post financial results for its latest quarter.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Leave a Reply

Your email address will not be published. Required fields are marked *